Insider Transactions in Q2 2021 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,500
-8.0%
|
$125,000
$50.0 P/Share
|
|
Jun 28
2021
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.41%
|
$75,000
$30.65 P/Share
|
|
Jun 14
2021
|
Mark S Shearman EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
32,701
+50.0%
|
-
|